Loading stock data...

Nureca Limited

NSE: NURECA BSE: NURECA

NSE
243.67 -0.91 (-0.37%)

Prev Close

244.58

Open Price

242.4

Volume

41,051

Today Low / High

239.1 / 245.9

52 WK Low / High

203.62 / 447.5

Range

231 - 256

BSE
242.80 -0.65 (-0.27%)

Prev Close

243.45

Open Price

243.3

Volume

455

Today Low / High

239.45 / 244.7

52 WK Low / High

198 / 447

Range

231 - 255

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 243.67 (target range: 231 - 256), reflecting a change of -0.91 (-0.37207%). On the BSE, it is listed at 242.8 (target range: 231 - 255), showing a change of -0.65 (-0.267%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

12 Aug 238.50 -1.61%
11 Aug 238.20 0.13%
08 Aug 234.00 1.27%
07 Aug 234.20 0.69%
06 Aug 238.10 -2.14%
05 Aug 241.10 -1.78%
04 Aug 241.94 -0.45%
01 Aug 250.00 -3.62%
31 Jul 238.30 4.51%
30 Jul 238.60 -0.13%
29 Jul 240.00 -1.10%
28 Jul 247.00 -2.43%

Nureca Limited Graph

Nureca Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Nureca Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 243.67, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 242.80 245.23 220.71 - 269.75
247.66 198.12 - 297.19
250.08 175.06 - 325.11
Bearish Scenario 242.80 240.37 216.33 - 264.41
237.94 190.36 - 285.53
235.52 164.86 - 306.17

Overview of Nureca Limited

ISIN

INE0DSF01015

Industry

Medical - Devices

Vol.Avg

12,410

Market Cap

2,346,646,932

Last Dividend

0

Official Website

Visit Website

IPO Date

2021-02-25

DCF Diff

252.45

DCF

-15

Financial Ratios Every Investor Needs

Stock Dividend of NURECA

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2022-02-24 February 24, 22 3 3 2022-02-25 2022-03-14
2021-09-21 September 21, 21 2 2 2021-09-22 2021-10-28

Stock Rating Details for NURECA

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 1 Strong Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 109.66 Cr 86.53 Cr 23.13 Cr 0.2110 0.00 Cr 2.17 Cr -9.55 Cr 0.85 Cr 0.85 4.90 Cr 0.0077
2024-03-31 91.93 Cr 60.79 Cr 31.14 Cr 0.3388 0.00 Cr 2.21 Cr -12.10 Cr -1.79 Cr -1.79 0.24 Cr -0.0195
2023-03-31 111.32 Cr 75.73 Cr 35.59 Cr 0.3197 0.00 Cr 3.43 Cr -17.14 Cr -8.25 Cr -8.25 -7.90 Cr -0.0741
2022-03-31 255.55 Cr 132.96 Cr 122.59 Cr 0.4797 0.00 Cr 5.22 Cr 54.81 Cr 44.96 Cr 44.96 63.20 Cr 0.1759
2021-03-31 213.45 Cr 99.68 Cr 113.78 Cr 0.5330 0.00 Cr 0.86 Cr 62.21 Cr 46.37 Cr 62.04 63.68 Cr 0.2173

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 3.24 Cr 209.98 Cr 15.69 Cr 194.2850 Cr 4.97 Cr 1.73 Cr 39.92 Cr 9.02 Cr 0.00 Cr 0.00 Cr 3.82 Cr 12.3990 Cr
2024-03-31 14.06 Cr 205.17 Cr 12.05 Cr 193.1110 Cr 2.52 Cr -11.55 Cr 30.85 Cr 5.08 Cr 0.48 Cr 0.00 Cr -99.60 Cr 9.2730 Cr
2023-03-31 0.50 Cr 206.58 Cr 11.70 Cr 194.8820 Cr 3.33 Cr 2.82 Cr 34.48 Cr 6.04 Cr 0.33 Cr 0.00 Cr 7.24 Cr 8.8830 Cr
2022-03-31 8.25 Cr 219.13 Cr 15.93 Cr 203.1970 Cr 4.41 Cr -3.84 Cr 63.18 Cr 7.80 Cr 0.94 Cr 0.00 Cr 1.95 Cr 12.2380 Cr
2021-03-31 17.24 Cr 185.75 Cr 22.65 Cr 163.0990 Cr 3.89 Cr -13.36 Cr 36.78 Cr 3.68 Cr -2.84 Cr 0.00 Cr 0.00 Cr 18.8670 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -19.0830 Cr 8.4390 Cr -0.1690 Cr -23.4060 Cr -10.8210 Cr 3.2410 Cr -4.3230 Cr 1.3430 Cr 1.8880 Cr 0.0000 Cr -9.0670 Cr
2024-03-31 -2.7120 Cr 17.5760 Cr -1.3030 Cr -3.7980 Cr 13.5580 Cr 14.0620 Cr -1.0860 Cr -2.5440 Cr -0.8210 Cr 0.0000 Cr 3.6260 Cr
2023-03-31 10.2270 Cr -16.4560 Cr -1.5070 Cr 9.8310 Cr -7.7450 Cr 0.5040 Cr -0.3960 Cr -10.7420 Cr 0.0060 Cr 0.0000 Cr 28.7000 Cr
2022-03-31 1.3990 Cr -3.0890 Cr -7.3020 Cr -4.6000 Cr -8.9930 Cr 8.2490 Cr -3.4040 Cr 60.9810 Cr -0.9220 Cr -4.9930 Cr -26.4010 Cr
2021-03-31 34.8670 Cr -110.0400 Cr 92.3390 Cr 34.1400 Cr 17.1680 Cr 17.2420 Cr -0.7270 Cr 62.3330 Cr -8.1490 Cr 0.0000 Cr -20.3500 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 34.18 Cr 22.18 Cr 12.00 Cr 0.3511 -1.09 Cr 0.81 Cr 0.81 2.01 Cr 0.0238
2025-03-31 31.74 Cr 18.97 Cr 12.77 Cr 0.4023 0.68 Cr 2.47 Cr 2.47 3.19 Cr 0.0777
2024-12-31 26.46 Cr 16.53 Cr 9.93 Cr 0.3753 -4.55 Cr -2.80 Cr -2.80 -2.54 Cr -0.1058
2024-09-30 31.19 Cr 24.52 Cr 6.67 Cr 0.2137 -2.98 Cr -0.48 Cr -0.48 0.81 Cr -0.0155
2024-06-30 20.27 Cr 16.46 Cr 3.81 Cr 0.1882 -3.03 Cr 1.66 Cr 1.66 3.43 Cr 0.0820

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 3.24 Cr 125.18 Cr 73.63 Cr 5.15 Cr 39.92 Cr 189.95 Cr 9.02 Cr 209.98 Cr 15.69 Cr
2024-12-31 0.00 Cr 0.00 Cr 28.29 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -194.31 Cr
2024-09-30 24.01 Cr 4.27 Cr 28.29 Cr 10.02 Cr 27.65 Cr 193.82 Cr 7.21 Cr 214.96 Cr 20.65 Cr
2024-06-30 -113.96 Cr 227.91 Cr 113.96 Cr 0.00 Cr 0.00 Cr 113.96 Cr 0.00 Cr 0.00 Cr -193.11 Cr
2024-03-31 14.06 Cr 99.89 Cr 113.96 Cr 1.62 Cr 30.85 Cr 192.59 Cr 5.08 Cr 205.17 Cr 12.05 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-03-31 2.47 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 -2.80 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -0.48 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.66 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 -4.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Devices

No stocks found in this industry.

Key Executives

Chief Financial Officer
Mr. Naresh Gupta

Gender: male

Year Born: 1980

Company Secretary & Compliance Officer
Ms. Nishu Kansai

Gender: female

Year Born: 1987

Whole-Time Director
Mr. Rajinder Sharma

Gender: male

Year Born: 1964

Vice President of Sales & Marketing
Mr. Rohit Saini

Gender: male

Year Born:

Assistant Manager of Investors Relations & Corporate Affairs
Mr. Gurvikram Singh

Gender: male

Year Born: 1990

Chief Officer Sales & Supply Chain
Mr. Vivek Gupta

Gender: male

Year Born: 1975

Co-Founder, MD & Chairman
Mr. Saurabh Goyal

Gender: male

Year Born: 1986

Co-Founder, Chief Executive Officer & Whole-time Director
Mr. Aryan Goyal

Gender: male

Year Born: 1983

FAQs about Nureca Limited

Who is the CEO of the company?

The CEO is Aryan Goyal.

What is the current market price of the stock?

The current price is ₹234.66.

What is the 52-week price range?

The range is ₹203.62-447.5.

What is the market capitalization of the company?

The market capitalization is ₹234.66 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is -78,509.70.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Nureca Limited (ISIN: INE0DSF01015) is a leading Medical - Devices in India. With a market capitalization of ₹234.66 crores and an average daily volume of 12,410 shares, it operates in the Medical - Devices. The company last declared a dividend of ₹0.

Welcome to the Investing and Trading Information platform: InvesTrack.in

Note: This platform is for educational and informational purposes only. Do not consider anything as financial advice.

QUICK LINKS

Home
About us
Contact us
Privacy Policy
Disclaimer
Sitemap
Investing
Trading
Top Brokers
Tools
Live Analysis

STAY CONNECTED

Follow Us On Social Media
Get Latest Update On Social Media
Facebook Instagram Twitter

General Disclaimer: InvesTrack is an educational platform and not any type of investment advisory platform. Our Blog and videos are based on countless hours of research and experience, which you can use as a guide for your research purposes. None of our content should be considered a piece of investment advice. Earning Disclosure: InvesTrack is a community supported platform. We may earn a commission when you make a purchase through one of our links at no extra cost to you. Note: We are not SEBI Registered Advisors. This website is purely for training and educational purposes. We shall not be responsible for your profit or loss.

© Copyright 2024 - 2025 | InvesTrack